Cargando…

Brachytherapy for primary nasal vestibule cancer using Au-198 grains

Radiation therapy (RT) is one of the definitive treatments for early-stage nasal vestibular carcinoma and has similar local control rates to resection surgery. There are various methods, including external beam RT and brachytherapy. This report describes a case who showed local control for more than...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Hinako, Ishikawa, Yojiro, Tanaka, Shohei, Kishida, Keita, Umezawa, Rei, Yamamoto, Takaya, Takahashi, Noriyoshi, Takeda, Kazuya, Suzuki, Yu, Jingu, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163247/
https://www.ncbi.nlm.nih.gov/pubmed/35669907
http://dx.doi.org/10.1007/s13691-022-00546-x
_version_ 1784719882760224768
author Harada, Hinako
Ishikawa, Yojiro
Tanaka, Shohei
Kishida, Keita
Umezawa, Rei
Yamamoto, Takaya
Takahashi, Noriyoshi
Takeda, Kazuya
Suzuki, Yu
Jingu, Keiichi
author_facet Harada, Hinako
Ishikawa, Yojiro
Tanaka, Shohei
Kishida, Keita
Umezawa, Rei
Yamamoto, Takaya
Takahashi, Noriyoshi
Takeda, Kazuya
Suzuki, Yu
Jingu, Keiichi
author_sort Harada, Hinako
collection PubMed
description Radiation therapy (RT) is one of the definitive treatments for early-stage nasal vestibular carcinoma and has similar local control rates to resection surgery. There are various methods, including external beam RT and brachytherapy. This report describes a case who showed local control for more than 5 years after brachytherapy alone using Au-198 grains for nasal vestibular carcinoma. A 68-year-old Japanese man complained of swelling and pain in his left nasal cavity. He was diagnosed with squamous cell carcinoma (SCC) (cT1N0M0, stage I). An elevated mass of 8 mm in long diameter was found inside the left nasal cavity. Since the patient selected brachytherapy, nine Au-198 grains 185 mBq were permanently injected percutaneously under local anesthesia, and 85 Gy was prescribed. Grade three dermatitis was observed as an acute adverse event. After 2 years, mild telangiectasia of the left nasal skin and epilation of nasal hair in the left nasal cavity was regarded as late adverse events. The patient continues to keep a complete response for 5 years. For small nasal vestibular SCC, brachytherapy with Au-198 grains might be a good option.
format Online
Article
Text
id pubmed-9163247
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-91632472022-06-05 Brachytherapy for primary nasal vestibule cancer using Au-198 grains Harada, Hinako Ishikawa, Yojiro Tanaka, Shohei Kishida, Keita Umezawa, Rei Yamamoto, Takaya Takahashi, Noriyoshi Takeda, Kazuya Suzuki, Yu Jingu, Keiichi Int Cancer Conf J Case Report Radiation therapy (RT) is one of the definitive treatments for early-stage nasal vestibular carcinoma and has similar local control rates to resection surgery. There are various methods, including external beam RT and brachytherapy. This report describes a case who showed local control for more than 5 years after brachytherapy alone using Au-198 grains for nasal vestibular carcinoma. A 68-year-old Japanese man complained of swelling and pain in his left nasal cavity. He was diagnosed with squamous cell carcinoma (SCC) (cT1N0M0, stage I). An elevated mass of 8 mm in long diameter was found inside the left nasal cavity. Since the patient selected brachytherapy, nine Au-198 grains 185 mBq were permanently injected percutaneously under local anesthesia, and 85 Gy was prescribed. Grade three dermatitis was observed as an acute adverse event. After 2 years, mild telangiectasia of the left nasal skin and epilation of nasal hair in the left nasal cavity was regarded as late adverse events. The patient continues to keep a complete response for 5 years. For small nasal vestibular SCC, brachytherapy with Au-198 grains might be a good option. Springer Nature Singapore 2022-04-08 /pmc/articles/PMC9163247/ /pubmed/35669907 http://dx.doi.org/10.1007/s13691-022-00546-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Report
Harada, Hinako
Ishikawa, Yojiro
Tanaka, Shohei
Kishida, Keita
Umezawa, Rei
Yamamoto, Takaya
Takahashi, Noriyoshi
Takeda, Kazuya
Suzuki, Yu
Jingu, Keiichi
Brachytherapy for primary nasal vestibule cancer using Au-198 grains
title Brachytherapy for primary nasal vestibule cancer using Au-198 grains
title_full Brachytherapy for primary nasal vestibule cancer using Au-198 grains
title_fullStr Brachytherapy for primary nasal vestibule cancer using Au-198 grains
title_full_unstemmed Brachytherapy for primary nasal vestibule cancer using Au-198 grains
title_short Brachytherapy for primary nasal vestibule cancer using Au-198 grains
title_sort brachytherapy for primary nasal vestibule cancer using au-198 grains
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163247/
https://www.ncbi.nlm.nih.gov/pubmed/35669907
http://dx.doi.org/10.1007/s13691-022-00546-x
work_keys_str_mv AT haradahinako brachytherapyforprimarynasalvestibulecancerusingau198grains
AT ishikawayojiro brachytherapyforprimarynasalvestibulecancerusingau198grains
AT tanakashohei brachytherapyforprimarynasalvestibulecancerusingau198grains
AT kishidakeita brachytherapyforprimarynasalvestibulecancerusingau198grains
AT umezawarei brachytherapyforprimarynasalvestibulecancerusingau198grains
AT yamamototakaya brachytherapyforprimarynasalvestibulecancerusingau198grains
AT takahashinoriyoshi brachytherapyforprimarynasalvestibulecancerusingau198grains
AT takedakazuya brachytherapyforprimarynasalvestibulecancerusingau198grains
AT suzukiyu brachytherapyforprimarynasalvestibulecancerusingau198grains
AT jingukeiichi brachytherapyforprimarynasalvestibulecancerusingau198grains